Tissue Engineering for Clinical Applications

Harvard Extension School

BIOT E-132

Section 1

CRN 26847

Begin Registration
Tissue engineering is now recognized as a way to lessen the global disease burden: novel methods for pancreatic islet regeneration can address diabetes; autologous cells for heart muscle regeneration can address coronary artery disease; and nerve regeneration technologies can be used to treat stroke. This course describes strategies of tissue engineering and focuses on the diseases tissue engineering can address. Each lecture identifies a specific disease (coronary artery disease, stroke, diabetes) and describes tissue-engineered scaffolds that can alleviate the disease. Students learn the underlying pathology of the disease, understand the latest advances in tissue engineering for treating the disease, and discuss prospective research areas for novel biomaterials to modify the disease process. In addition, students gain an appreciation of clinical trials of tissue-engineered scaffolds, as well as commercialization of tissue engineering. Students may not take both BIOT E-132 and ENSC E-132 for degree or certificate credit.

Instructor Info

Sujata K. Bhatia, PhD

Professor of Microbiology and Immunology, Drexel University College of Medicine


Meeting Info

W 8:10pm - 10:10pm (1/27 - 5/17)

Participation Option: Online Synchronous

Deadlines

Last day to register: January 23, 2025

Prerequisites

Introductory biology and chemistry.

Notes

This course meets via web conference. Students must attend and participate at the scheduled meeting time.

Syllabus

All Sections of this Course

CRN Section # Participation Option(s) Instructor Section Status Meets Term Dates
26847 1 Online Synchronous Sujata Bhatia Open W 8:10pm - 10:10pm
Jan 27 to May 17